Insider Trading activities of Agios Pharmaceuticals Inc insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Agios Pharmaceuticals Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Agios Pharmaceuticals Inc since year 2005. Table 2 shows the detailed insider transactions of Agios Pharmaceuticals Inc since 2005. The reporting company's ticker symbol is AGIO. The reporting company's CIK number is 1439222.
The total value of stock buying since 2005 is $207,176,089.
The total value of stock sales since 2005 is $116,037,357.
The total value of stock option exercises since 2005 is $5,218,891.


 1   2 
Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Agios Pharmaceuticals Inc (AGIO).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2017-12 0 $0 11,984 $729,465 54,941 $120,770
2017-11 0 $0 12,146 $770,413 8,146 $69,717
2017-10 0 $0 100,470 $7,029,040 86,000 $26,058
2017-09 0 $0 68,146 $4,482,790 49,146 $242,803
2017-08 0 $0 54,146 $3,225,357 29,146 $27,602
2017-07 0 $0 14,146 $778,730 5,146 $20,330
2017-06 0 $0 9,292 $487,850 13,292 $37,014
2017-05 0 $0 5,036 $246,064 3,000 $909
2017-04 3,122,875 $154,582,310 10,236 $577,002 5,146 $20,330
2017-03 0 $0 11,474 $613,631 9,438 $31,547
2017-02 0 $0 384,446 $19,071,227 6,000 $1,818
2016-11 0 $0 37,500 $2,412,500 27,500 $377,272
2016-10 0 $0 7,504 $397,545 0 $0
2016-09 0 $0 7,504 $385,403 0 $0
2016-08 0 $0 2,504 $93,424 0 $0
2016-07 0 $0 2,504 $107,158 0 $0
2016-06 0 $0 30,004 $1,892,354 42,700 $448,597
2016-05 0 $0 2,504 $129,431 0 $0
2016-04 0 $0 2,504 $133,813 0 $0
2016-03 0 $0 2,504 $93,110 0 $0
2016-02 0 $0 0 $0 10,000 $4,680
2016-01 0 $0 2,504 $107,484 113,999 $1,021,533
2015-12 0 $0 36,164 $2,053,216 5,500 $174,020
2015-11 0 $0 40,408 $2,580,175 31,000 $369,900
2015-10 0 $0 33,704 $2,335,336 24,000 $133,720
2015-09 0 $0 41,204 $3,533,322 46,356 $308,496
2015-08 0 $0 43,204 $4,200,921 53,500 $313,908
2015-07 0 $0 55,204 $6,336,988 45,500 $485,992
2015-06 0 $0 40,204 $4,599,001 42,800 $188,539
2015-05 0 $0 46,721 $5,163,867 12,171 $53,180
2015-04 0 $0 29,587 $2,963,664 0 $0
2015-03 0 $0 42,604 $4,423,064 15,500 $187,344
2015-02 0 $0 29,700 $3,292,914 42,829 $251,334
2015-01 0 $0 53,500 $5,889,280 4,500 $2,106
2014-12 230,451 $25,522,447 29,500 $2,862,385 4,500 $2,106
2014-11 0 $0 32,500 $2,655,575 14,000 $15,354
2014-10 0 $0 32,000 $1,922,240 8,500 $16,438
2014-09 0 $0 155,996 $8,542,123 113,241 $118,585
2014-08 0 $0 29,500 $1,188,524 21,500 $8,082
2014-07 0 $0 33,000 $1,535,160 8,000 $6,183
2014-06 2,300 $101,154 18,504 $719,876 6,504 $3,043
2014-05 0 $0 18,500 $800,914 9,500 $5,345
2014-04 297,050 $13,070,200 25,500 $1,006,490 55,500 $26,031
2014-03 0 $0 46,114 $1,760,046 225,114 $73,400
2014-02 0 $0 25,886 $752,526 25,886 $10,405
2014-01 0 $0 35,000 $1,155,959 35,000 $14,400
2013-07 772,221 $13,899,978 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Agios Pharmaceuticals Inc insiders (AGIO)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2017-12-07 Cantley Lewis Clayton Jr. (Director) Sale 1,838 60.06 110,399
2017-12-06 Biller Scott (Chief Scientific Officer) Option Ex 46,795 1.09 51,053
2017-12-06 Cantley Lewis Clayton Jr. (Director) Sale 2,000 58.95 117,906
2017-12-01 Biller Scott (Chief Scientific Officer) Sale 2,146 60.76 130,390
2017-12-01 Biller Scott (Chief Scientific Officer) Option Ex 2,146 31.64 67,899
2017-12-01 Schenkein David P (Chief Executive Officer) Sale 6,000 61.80 370,770
2017-12-01 Schenkein David P (Chief Executive Officer) Option Ex 6,000 .30 1,818
2017-11-14 Cantley Lewis Clayton Jr. (Director) Sale 2,000 59.91 119,820
2017-11-13 Cantley Lewis Clayton Jr. (Director) Sale 2,000 62.07 124,140
2017-11-01 Biller Scott (Chief Scientific Officer) Sale 2,146 63.49 136,255
2017-11-01 Biller Scott (Chief Scientific Officer) Option Ex 2,146 31.64 67,899
2017-11-01 Schenkein David P (Chief Executive Officer) Sale 6,000 65.03 390,198
2017-11-01 Schenkein David P (Chief Executive Officer) Option Ex 6,000 .30 1,818
2017-10-17 Cantley Lewis Clayton Jr. (Director) Sale 2,000 71.10 142,200
2017-10-16 Cantley Lewis Clayton Jr. (Director) Sale 2,000 71.09 142,180
2017-10-04 Biller Scott (Chief Scientific Officer) Sale 10,470 70.00 732,900
2017-10-04 Schenkein David P (Chief Executive Officer) Sale 80,000 70.14 5,611,200
2017-10-04 Schenkein David P (Chief Executive Officer) Option Ex 80,000 .30 24,240
2017-10-02 Schenkein David P (Chief Executive Officer) Sale 6,000 66.76 400,560
2017-10-02 Schenkein David P (Chief Executive Officer) Option Ex 6,000 .30 1,818
2017-09-18 Schenkein David P (Chief Executive Officer) Sale 35,000 67.12 2,349,200
2017-09-18 Schenkein David P (Chief Executive Officer) Option Ex 35,000 .30 10,605
2017-09-14 Cantley Lewis Clayton Jr. (Director) Sale 2,000 65.71 131,420
2017-09-13 Cantley Lewis Clayton Jr. (Director) Sale 2,000 65.47 130,940
2017-09-11 Bowden Christopher (Chief Medical Officer) Sale 6,000 65.00 390,000
2017-09-11 Bowden Christopher (Chief Medical Officer) Option Ex 6,000 35.16 210,959
2017-09-11 Biller Scott (Chief Scientific Officer) Sale 15,000 65.00 975,000
2017-09-01 Biller Scott (Chief Scientific Officer) Sale 2,146 61.99 133,030
2017-09-01 Biller Scott (Chief Scientific Officer) Option Ex 2,146 9.05 19,421
2017-09-01 Schenkein David P (Chief Executive Officer) Sale 6,000 62.20 373,200
2017-09-01 Schenkein David P (Chief Executive Officer) Option Ex 6,000 .30 1,818
2017-08-23 Cantley Lewis Clayton Jr. (Director) Sale 2,000 57.08 114,160
2017-08-22 Cantley Lewis Clayton Jr. (Director) Sale 2,000 56.62 113,240
2017-08-02 Biller Scott (Chief Scientific Officer) Sale 21,000 60.06 1,261,260
2017-08-02 Schenkein David P (Chief Executive Officer) Sale 24,000 60.55 1,453,200
2017-08-02 Schenkein David P (Chief Executive Officer) Option Ex 24,000 .30 7,272
2017-08-01 Biller Scott (Chief Scientific Officer) Sale 2,146 55.05 118,137
2017-08-01 Biller Scott (Chief Scientific Officer) Option Ex 2,146 9.05 19,421
2017-08-01 Schenkein David P (Chief Executive Officer) Sale 3,000 55.12 165,360
2017-08-01 Schenkein David P (Chief Executive Officer) Option Ex 3,000 .30 909
2017-07-20 Cantley Lewis Clayton Jr. (Director) Sale 2,000 57.12 114,250
2017-07-19 Cantley Lewis Clayton Jr. (Director) Sale 7,000 56.13 392,910
2017-07-07 Biller Scott (Chief Scientific Officer) Sale 2,146 55.00 118,030
2017-07-07 Biller Scott (Chief Scientific Officer) Option Ex 2,146 9.05 19,421
2017-07-03 Schenkein David P (Chief Executive Officer) Sale 3,000 51.18 153,540
2017-07-03 Schenkein David P (Chief Executive Officer) Option Ex 3,000 .30 909
2017-06-23 Biller Scott (Chief Scientific Officer) Option Ex 3,000 .47 1,404
2017-06-21 Biller Scott (Chief Scientific Officer) Sale 4,292 55.00 236,060
2017-06-21 Biller Scott (Chief Scientific Officer) Option Ex 7,292 4.76 34,702
2017-06-14 Cantley Lewis Clayton Jr. (Director) Sale 1,000 51.09 51,090
2017-06-13 Cantley Lewis Clayton Jr. (Director) Sale 1,000 50.64 50,640
2017-06-07 Schenkein David P (Chief Executive Officer) Sale 1,900 50.02 95,038
2017-06-07 Schenkein David P (Chief Executive Officer) Option Ex 1,900 .30 575
2017-06-06 Schenkein David P (Chief Executive Officer) Sale 1,100 50.02 55,022
2017-06-06 Schenkein David P (Chief Executive Officer) Option Ex 1,100 .30 333
2017-05-25 Cantley Lewis Clayton Jr. (Director) Sale 1,018 46.92 47,764
2017-05-24 Cantley Lewis Clayton Jr. (Director) Sale 1,018 47.27 48,120
2017-05-01 Schenkein David P (Chief Executive Officer) Sale 3,000 50.06 150,180
2017-05-01 Schenkein David P (Chief Executive Officer) Option Ex 3,000 .30 909
2017-04-24 Celgene Corp /de/ (10% Owner) Buy 1,873,725 49.50 92,749,386
2017-04-18 Cantley Lewis Clayton Jr. (Director) Sale 1,018 50.92 51,836
2017-04-17 Cantley Lewis Clayton Jr. (Director) Sale 4,072 55.20 224,774
2017-04-03 Biller Scott (Chief Scientific Officer) Sale 2,146 58.03 124,532
2017-04-03 Biller Scott (Chief Scientific Officer) Option Ex 2,146 9.05 19,421
2017-04-03 Schenkein David P (Chief Executive Officer) Sale 3,000 58.62 175,860
2017-04-03 Schenkein David P (Chief Executive Officer) Option Ex 3,000 .30 909
2017-03-23 Cantley Lewis Clayton Jr. (Director) Sale 1,018 53.91 54,880
2017-03-22 Cantley Lewis Clayton Jr. (Director) Sale 1,018 52.31 53,251
2017-03-20 Biller Scott (Chief Scientific Officer) Sale 6,438 55.00 354,090
2017-03-20 Biller Scott (Chief Scientific Officer) Option Ex 6,438 4.76 30,638
2017-03-01 Schenkein David P (Chief Executive Officer) Sale 3,000 50.47 151,410
2017-03-01 Schenkein David P (Chief Executive Officer) Option Ex 3,000 .30 909
2017-02-28 Nelsen Robert (Director) Sale 47,859 49.82 2,384,431
2017-02-27 Nelsen Robert (Director) Sale 195,223 49.26 9,616,294
2017-02-23 Nelsen Robert (Director) Sale 50,996 48.24 2,459,894
2017-02-22 Nelsen Robert (Director) Sale 47,938 50.12 2,402,892
2017-02-21 Nelsen Robert (Director) Sale 36,430 52.37 1,907,656
2017-02-16 Schenkein David P (Chief Executive Officer) Sale 6,000 50.01 300,060
2017-02-16 Schenkein David P (Chief Executive Officer) Option Ex 6,000 .30 1,818
2016-11-14 Biller Scott (Chief Scientific Officer) Sale 32,500 65.00 2,112,500
2016-11-14 Biller Scott (Chief Scientific Officer) Option Ex 27,500 13.72 377,272
2016-11-10 Biller Scott (Chief Scientific Officer) Sale 2,128 60.00 127,680
2016-11-09 Biller Scott (Chief Scientific Officer) Sale 2,872 60.00 172,320
2016-10-27 Cantley Lewis Clayton Jr. (Director) Sale 1,252 48.97 61,310
2016-10-26 Cantley Lewis Clayton Jr. (Director) Sale 1,252 48.91 61,235
2016-10-05 Biller Scott (Chief Scientific Officer) Sale 5,000 55.00 275,000
2016-09-28 Cantley Lewis Clayton Jr. (Director) Sale 1,252 54.00 67,608
2016-09-27 Cantley Lewis Clayton Jr. (Director) Sale 1,252 54.15 67,795
2016-09-20 Biller Scott (Chief Scientific Officer) Sale 5,000 50.00 250,000
2016-08-30 Cantley Lewis Clayton Jr. (Director) Sale 1,252 36.81 46,086
2016-08-29 Cantley Lewis Clayton Jr. (Director) Sale 1,252 37.81 47,338
2016-07-26 Cantley Lewis Clayton Jr. (Director) Sale 1,252 43.74 54,762
2016-07-25 Cantley Lewis Clayton Jr. (Director) Sale 1,252 41.85 52,396
2016-06-28 Cantley Lewis Clayton Jr. (Director) Sale 1,252 43.38 54,311
2016-06-27 Cantley Lewis Clayton Jr. (Director) Sale 1,252 40.37 50,543
2016-06-10 Biller Scott (Chief Scientific Officer) Option Ex 15,200 .47 7,113
2016-06-08 Biller Scott (Chief Scientific Officer) Sale 27,500 65.00 1,787,500
2016-06-08 Biller Scott (Chief Scientific Officer) Option Ex 27,500 16.05 441,484
2016-05-26 Cantley Lewis Clayton Jr. (Director) Sale 1,252 52.88 66,205
2016-05-25 Cantley Lewis Clayton Jr. (Director) Sale 1,252 50.50 63,226
2016-04-26 Cantley Lewis Clayton Jr. (Director) Sale 1,252 51.88 64,953
2016-04-25 Cantley Lewis Clayton Jr. (Director) Sale 1,252 55.00 68,860
2016-03-30 Cantley Lewis Clayton Jr. (Director) Sale 1,252 38.09 47,688
2016-03-29 Cantley Lewis Clayton Jr. (Director) Sale 1,252 36.28 45,422
2016-02-03 Biller Scott (Chief Scientific Officer) Option Ex 10,000 .47 4,680
2016-01-29 Cantley Lewis Clayton Jr. (Director) Sale 1,252 41.52 51,983
2016-01-28 Cantley Lewis Clayton Jr. (Director) Sale 1,252 44.33 55,501
2016-01-07 Biller Scott (Chief Scientific Officer) Option Ex 15,000 .47 7,020
2016-01-07 Schenkein David P (Chief Executive Officer) Option Ex 20,000 .30 6,060
2016-01-05 Schenkein David P (Chief Executive Officer) Option Ex 10,000 .30 3,030
2016-01-04 Higgons John Duncan (Chief Operating Officer) Option Ex 58,999 16.99 1,002,393
2016-01-04 Schenkein David P (Chief Executive Officer) Option Ex 10,000 .30 3,030
2015-12-31 Biller Scott (Chief Scientific Officer) Sale 5,500 65.27 358,985
2015-12-31 Biller Scott (Chief Scientific Officer) Option Ex 5,500 31.64 174,020
2015-12-29 Cantley Lewis Clayton Jr. (Director) Sale 5,340 66.14 353,160
2015-12-28 Cantley Lewis Clayton Jr. (Director) Sale 5,324 63.73 339,271
2015-12-15 Higgons John Duncan (Chief Operating Officer) Sale 20,000 50.09 1,001,800
2015-11-30 Biller Scott (Chief Scientific Officer) Sale 5,500 65.99 362,945
2015-11-30 Biller Scott (Chief Scientific Officer) Option Ex 5,500 31.64 174,020
2015-11-17 Cantley Lewis Clayton Jr. (Director) Sale 6,982 59.98 418,815
2015-11-16 Higgons John Duncan (Chief Operating Officer) Sale 20,000 61.51 1,230,200
2015-11-16 Higgons John Duncan (Chief Operating Officer) Option Ex 20,000 1.09 21,860
2015-11-16 Cantley Lewis Clayton Jr. (Director) Sale 2,426 59.38 144,055
2015-11-02 Biller Scott (Chief Scientific Officer) Sale 5,500 77.12 424,160
2015-11-02 Biller Scott (Chief Scientific Officer) Option Ex 5,500 31.64 174,020
2015-10-27 Schenkein David P (Chief Executive Officer) Sale 4,000 80.26 321,040
2015-10-27 Schenkein David P (Chief Executive Officer) Option Ex 4,000 31.64 126,560
2015-10-23 Cantley Lewis Clayton Jr. (Director) Sale 4,852 61.10 296,481
2015-10-22 Cantley Lewis Clayton Jr. (Director) Sale 4,852 61.22 297,015
2015-10-15 Higgons John Duncan (Chief Operating Officer) Sale 20,000 71.04 1,420,800
2015-10-15 Higgons John Duncan (Chief Operating Officer) Option Ex 20,000 .36 7,160
2015-09-30 Biller Scott (Chief Scientific Officer) Sale 5,500 70.44 387,420
2015-09-30 Biller Scott (Chief Scientific Officer) Option Ex 5,500 31.64 174,020
2015-09-30 Higgons John Duncan (Chief Operating Officer) Option Ex 10,000 .30 3,030
2015-09-25 Cantley Lewis Clayton Jr. (Director) Sale 4,852 82.08 398,252
2015-09-24 Goddard Glenn (Senior Vice President, Finance) Sale 6,000 85.97 515,820
2015-09-24 Goddard Glenn (Senior Vice President, Finance) Option Ex 10,856 11.55 125,386
2015-09-24 Cantley Lewis Clayton Jr. (Director) Sale 4,852 84.42 409,630
2015-09-15 Higgons John Duncan (Chief Operating Officer) Sale 20,000 91.11 1,822,200
2015-09-15 Higgons John Duncan (Chief Operating Officer) Option Ex 20,000 .30 6,060
2015-08-20 Higgons John Duncan (Chief Operating Officer) Option Ex 10,000 .30 3,030
2015-08-18 Cantley Lewis Clayton Jr. (Director) Sale 4,852 95.69 464,287
2015-08-17 Higgons John Duncan (Chief Operating Officer) Sale 20,000 92.24 1,844,800
2015-08-17 Higgons John Duncan (Chief Operating Officer) Option Ex 20,000 .30 6,060
2015-08-17 Cantley Lewis Clayton Jr. (Director) Sale 4,852 94.19 457,034
2015-08-10 Biller Scott (Chief Scientific Officer) Sale 5,500 100.00 550,000
2015-08-10 Biller Scott (Chief Scientific Officer) Option Ex 5,500 31.64 174,020
2015-08-06 Higgons John Duncan (Chief Operating Officer) Option Ex 10,000 .30 3,030
2015-08-03 Schenkein David P (Chief Executive Officer) Sale 8,000 110.60 884,800
2015-08-03 Schenkein David P (Chief Executive Officer) Option Ex 8,000 15.97 127,768
 1   2 

Insider trading activities including stock purchases, stock sales, and option exercises of AGIO listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Agios Pharmaceuticals Inc (symbol AGIO, CIK number 1439222) see the Securities and Exchange Commission (SEC) website.